Usage of C-reactive protein testing in the diagnosis and monitoring of psoriatic arthritis (PsA): results from a real-world survey in the USA and Europe
<strong>Introduction<br></strong> C-reactive protein (CRP) is an important non-specific marker of both acute and chronic inflammation and can be elevated in patients with psoriatic arthritis (PsA). However, the use of CRP testing in the management of PsA can vary. This study invest...
Main Authors: | Ogdie, A, Tillett, W, Booth, N, Howell, O, Schubert, A, Peterson, S, Chakravarty, SD, Coates, LC |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Springer Nature
2022
|
Títulos similares
-
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
por: Coates, LC, et al.
Publicado: (2021) -
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC
por: Coates, LC, et al.
Publicado: (2022) -
Sex-specific challenges in patients with psoriatic arthritis (PsA): preliminary results from a systematic literature review (SLR)
por: Coates, LC, et al.
Publicado: (2021) -
Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
por: Helliwell, PS, et al.
Publicado: (2022) -
Psoriatic arthritis: prospects for the future
por: Hackett, S, et al.
Publicado: (2022)